The site uses cookies to provide you with a better experience. By using this site you agree to our Privacy policy.

BIOME AUSTRALIA LIMITED DEBUTS ON THE ASX WITH ~ $8M RAISED AT IPO

BIOME AUSTRALIA LIMITED DEBUTS ON THE ASX WITH ~ $8M RAISED AT IPO

Moore Australia

Moore Australia congratulates client Biome Australia, for its successful listing on the Australian Stock Exchange (ASX) today (ASX: BIO).

“We are delighted for Biome and for being able to be part of their journey in listing today”, says Moore Australia Victoria Corporate Finance Director, Colin Prasad. It was a pleasure working with Douglas Loh (CFO), Blair Norfolk (MD) and team. 

Moore Australia (Vic) Partners Colin Prasad, and Andrew Johnson (Audit) led the client service team which provided an Independent Accountants Report for the prospectus, which preceded the ASX listing.

About Biome Australia
Founded in Australia in 2018, Biome Australia develops, commercialises and markets innovative, evidence-based live biotherapeutics and complementary medicines with clinically proven health benefits.  It aims to prevent disease, improve health outcomes and quality of life and make its products accessible to all.